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The importance of luck in a scientific 
career: 
“I'm a great believer in luck, and I find the 
harder I work the more I have of it”  
 - Thomas Jefferson 
The importance of luck in a scientific 
career: 
• Training / Research environments 
 
• Scientific colleagues 
 
• A bit of experimental “luck” 
“Chance [luck] favors the prepared mind” 
 - Louis Pasteur  
Thomas Jefferson University c. 1994 
• Carlo Croce had recently been named Cancer Center 
Director 
• Immunology had an exciting nexus of labs: 
– Bob Korngold, Tim Manser, Bice Perussia, Cathy Calkins, 
Craig Hooper, Ned Lattime, Ike Eisenlohr, Etc. 
• The Jefferson “Cohort” – Tremendous Colleagues 
– Tim Bullock – UVA 
– Kim Bullock – UVA 
– Dan Powell – UPenn 
– De’Broski Herbert – UCSF 
– Mike Hsieh – Stanford 
– John Russell – Biotech 
– Brian Halak – Venture Capital 
– Kalpit Vora – Merck 
 
 
T cell responses to viral infection  - 
Eisenlohr lab 
How does the dose of antigen impact T cell responses?   
NP50–57-speciﬁc response, wells also received 2 10
5 L929 cells irradi-
ated with 10,000 cGy and pulsed with peptide (as above), infected with
irrelevant vac (as above), or left untreated. For the OVA257–264-speciﬁc
response, wells also received 2 105 EL-4 cells irradiated with 10,000
cGy, EL-4 cells irradiated with 10,000 cGy and infected with irrelevant vac
(as above), or EL-4.OVA cells irradiated with 10,000 cGy. Plates were
incubated at 37°C with 6% CO2 for 18–24 h, washed extensively, and
incubated for 2 h to overnight with a second biotinylated anti-IFN- Ab at
4 g/ml (PharMingen). After washing, 10 g/ml HRP-conjugated avidin D
(Vector Laboratories) was added to each well and the plate was incubated
at room temperature for 2 h. Following further washing, spots were de-
veloped using 3,3 diaminobenzidine and -chloronaphthol dissolved in
methanol and added to 10 ml PBS containing 20 l H2O2 (30%). Spots
were counted using a dissecting microscope by two separate investigators,
one of whom was blinded to the experimental design.
Results
Ag expression system
The model Ag used for most studies is depicted in Fig. 1. It is
composed of the full-length inﬂuenza A PR/8/34 nucleoprotein
(NP) with aa 257–264 of chicken OVA inserted as shown (single
letter code SIINFEKL). NP contains three well-deﬁned murine
CTL epitopes (NP50–57 restricted to H-2K
k, NP147–155 restricted to
H-2Kd, and NP366–374 restricted to H-2D
b) that we have reported
on previously (40, 41, 44, 48, 49). Responses to the H-2Kb-re-
stricted OVA257–264 epitope have been studied extensively, lead-
ing to the generation of reagents exploited here. The resulting pro-
tein, encoding all four CTL epitopes is termed NP/SIINFEKL
(NP/S).
It has been previously shown that a thermostable duplex barrier
of 20 bp located between the promoter and start site of the NP gene
expressed by recombinant vac blocks in vitro presentation of the
NP147–155 epitope and substantially decreases presentation of the
NP50–57 and NP366–374 epitopes (40). Progressive elimination of
base pairs within this HP was subsequently shown to allow a wide
range of Ag expression (41). To obtain a full spectrum of re-
sponses, additional HP constructs were developed. In all, seven
HPs of different sizes were generated and inserted in front of the
NP/S gene (Fig. 1). The HP constructs are termed according to the
number of base pairs in the duplex. For example, HP17 contains a
17-bp thermostable duplex barrier before the start codon of the NP
gene (see Materials and Methods). In addition, the wild-type con-
struct without a HP, termed HP0, and minigene constructs for each
epitope were utilized. The minigene constructs, encoding the min-
imal epitope preceded by only an initiating methionine, induce
very high numbers of epitope/class I complexes at the cell surface
(36, 37), likely due to the minimal processing required before
transport and loading onto class I molecules. Thus, equivalent in-
fection by a panel of vacs expressing the different constructs is
expected to result in a wide range of cell surface epitope/MHC
class I complexes.
The effect of the HP series on protein expression was assessed
by measuring steady state levels of NP/S. L cells transfected with
the H-2Kb gene (L-Kb) were infected with 5 pfu/cell of the various
vac HP constructs for 8 h, lysed, and subjected to Western blot
analysis with an Ab speciﬁc for wild-type NP. Fig. 2A shows a
Western blot of NP/S from the HP series and illustrates the dose-
dependent effect of HP size on the amount of the NP/S protein
detectable. With this relatively insensitive technique, expression of
FIGURE 1. Schematic diagram of NP/SIINFEKL behind the HP series.
FIGURE 2. HP size alters the level of protein production. A, Lysates
from L-Kb cells infected for 8 h with 5 pfu/cell of the indicated recombi-
nant vacs and uninfected cells were subjected to SDS-PAGE, transferred to
nitrocellulose, blotted with the anti-NP Ab, a secondary peroxidase-labeled
goat anti-mouse Ab, and developed. B, L-Kb cells were infected with 5
pfu/cell of the indicated viruses in BSS/BSA for 1 h. Complete medium
with 35S-labeled Met/Cys was added, and after 7 additional h of infection,
cells were lysed and protein A-agarose-cleared lysates were subjected to
immunoprecipitation with the H19-S24 anti-NP Ab and analyzed by SDS-
PAGE followed by autoradiography. The HP19 lane may have received
more material than other lanes as indicated by the increase in signal for the
nonspeciﬁc band migrating just below the speciﬁc NP/S band. C, L-Kb
cells were infected with 5 pfu/cell of the indicated HP vacs expressing
luciferase instead of NP/S and vac expressing NP as a control. After 8 h of
infection, cells were lysed and the luciferase substrate was added and lu-
ciferase activity measured as described in Materials and Methods. D, C3H
mice were infected i.p. with 107 pfu/mouse of the indicated luciferase HP
vacs. Approximately 48 h later spleens were removed and homogenized,
and 107 spleen cells/mouse were analyzed for luciferase activity as in C.
Similar results were obtained for C57BL/6 mice (data not shown).
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Wherry et al J. Immunol. 1999 
Ag (peptide) production 
Quantifying antigen-specific T cells c. 
1997 
Limiting Dilution Analysis 
The field transforms T cell analysis 
• Keystone 1998 – Tetramers Arrive! 
– Altman, Science 1996 
• Counting Antigen-specific T cells 
– Murali-Krishna Immunity 1998; Flynn Immunity 1998; 
Busch Immunity 1998 
 
 
 
 
 
 
• T cell exhaustion 
– Zajac JEM 1998 
40+ Plates  1 flow stain 
Chronic infections and T cell exhaustion 
• High dose immune paralysis/exhaustion  
• T cell exhaustion – T cells you could see with 
tetramers, but did not function 
• Evidence for T cell exhaustion/dysfunction in HIV, 
HCV and human cancer 
 
• What are the molecular mechanisms of this 
exhaustion? 
• Is exhaustion reversible? 
The “luck” of the right post doctoral 
environment – Ahmed lab 2000-2004 
HIV-specific CD8 T cells express low levels of IL-7Rα:
Implications for HIV-specific T cell memory
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Abstract
Chronic infections in mice can result in defects in memory CD8 T cell properties including low expression of the IL-7Rα (CD127). To
determine whether defects in memory CD8 T cell formation exist during human chronic infections and to what extent these defects may be allele-
or epitope-specific, we compared influenza (Flu), vaccinia (VV) and EBV-specific CD8 T cells to HIV-specific CD8 T cells, using a panel of 13
HIV tetramers. Compared to Flu, VV or EBV, HIV tetramer+ CD8 T cells expressed significantly lower levels of CD127, and this reduction was
pervasive across all epitopes and alleles tested and over a wide range of viral loads and CD4 counts. These results indicate impaired HIV-specific
memory CD8 T cell differentiation, regardless of level of control of viremia, epitopes targeted or restricting HLA alleles.
© 2006 Elsevier Inc. All rights reserved.
Keywords: HIV; CD8 T cell; Immunological memory; T cell memory; Chronic infection; IL-7rα
Introduction
Chronic viral infections are often associated with loss of
virus-specific CD8 T cell effector functions (e.g. cytokine
production or cytotoxicity) (Wherry and Ahmed, 2004). Such
functional impairment has been observed in mouse models
(Fuller et al., 2004; Gallimore et al., 1998; Ou et al., 2001;
Wherry et al., 2003; Zajac et al., 1998; Zhou et al., 2002) and
also in humans (Goepfert et al., 2000; Greten et al., 1998;
Kelleher and Rowland-Jones, 2000; Kostense et al., 2001;
Lechner et al., 2000; Reignat et al., 2002; Shankar et al.,
2000; Trimble et al., 2000; Trimble and Lieberman, 1998;
Urbani et al., 2002; Vogel et al., 2001; Xiong et al., 2001).
Recent studies in mice have found that virus-specific CD8 T
cells during chronic infections also fail to develop normal
memory CD8 T cell properties such as antigen-independent
persistence and homeostatic proliferation (Fuller et al., 2005;
Lang et al., 2005; Obar et al., 2004; Wherry et al., 2004). For
example, during chronic LCMV infection, virus-specific CD8
T cells are unable to respond to the homeostatic cytokines IL-
7 and IL-15 and their numbers decline when removed from
antigen (Wherry et al., 2004). These defects are in stark
contrast to the IL-7 and IL-15 dependent self-renewal and
maintenance of memory CD8 T cells following resolution of
an acute infection (Kaech et al., 2002; Schluns and
Lefrancois, 2003; Wherry and Ahmed, 2004). Substantial
reduction in the levels of IL-7 and IL-15 receptors during
chronic infection may be a central cause for the poor antigen-
independent memory T cell properties (Fuller et al., 2005;
Lang et al., 2005; Obar et al., 2004; Wherry et al., 2004). It
remains unclear, however, whether defects in memory CD8 T
cell maintenance pathways also arise during human chronic
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A model of T cell exhaustion 
Why did we care about T cell exhaustion 
? 
• T cell exhaustion was also being defined in HIV, HCV, 
HBV, HTLV-I, SIV, FLV, MHV, Leishmania, Malaria, Tb 
• T cell exhaustion in cancer 
• T cell exhaustion prevented optional viral / tumor 
control 
• Understanding fate choices for T cell exhaustion could 
teach us about optimal T cell memory 
 
• 1/3 of humanity is chronically infected with pathogens 
that cause disease! 
• Malaria – 300-500 million 
• HBV – 500 million 
• HCV – 170 million 
• HIV – 30 million 
• Helminths, mTb, Etc….  
Global Burden of Chronic Infections 
>20 Billion persisting viral infections in humanity 
Virgin, et al Cell 2009 
Could we define the underling 
molecular mechanisms of T cell 
exhaustion? 
Molecular profiling of T cell exhaustion 
c. 2000-2001 
Wherry, Immunity 2007 
Of top 3 overepressed genes: 
PD-1 
PD-1 in 2001 
• Cloned by Honjo in 1992 from dying T cells 
 
• Member of Ig Superfamily upregulated by T cell activation 
 
• Implications of PD-1 as a negative regulator of B cells (Honjo 1998) 
 
• PD-1 contains an ITIM and gene disruption provokes autoimmunity 
(Honjo 1999/2001) 
 
• PD-1 engagement may inhibit lymphocyte activation 
(Freeman/Honjo 2000) 
 
• PD-L1 and PD-L2 identified as ligands (Honjo 2001; Sharpe/Freeman 
2001) 
“Chance [luck] favors the prepared mind” 
 - Louis Pasteur  
  
• Dan Barber- graduate student in the Ahmed 
lab 
– “there must be an inhibitory receptor on 
exhausted T cells” – c. fall 2000  
– First microarray data January 2001 
 
• Rafi Ahmed, Arlene Sharpe and Gordon 
Freeman were graduate students together 
 
Reversing Exhaustion – PD-1 
40 54 
PD-1- translation to the clinic 
PD-1 pathway blockade:  
Good but can we do better? 
-    Heterogeneity in responses 
- Incomplete reversal of exhaustion 
- Even in mice PD-1 pathway blockade does not “cure” infections  
What are the molecular mechanisms 
of CD8 T cell exhaustion 
LCMV 
Arm or clone 13 
Exhaustion 
Modest/Early                                    Severe/Full 
Mild/Pre                        Moderate/Partial 
Transcriptional Profiling 
Arrays 
Arm: 
clone 13: 
0    6        8           15               30        day p.i.     
Wherry, Immunity 2007; Doering, Immunity 2012; Crawford, Immunity 2014 
N
ai
ve
 
D
ay
 6
 
D
ay
 8
 
D
ay
 1
5
 
D
ay
 3
0
 
D
ay
 6
 
D
ay
 8
 
D
ay
 1
5
 
D
ay
 3
0
 
Sorted on DbGP33 tetramer+ CD8 T cells from 
LCMV Armstrong or clone 13 infection 
Acute Chronic 
Wherry, Immunity, 2007 
Doering, Immunity, 2012 
Crawford, Immunity, 2014 
Transcriptional Program of Exhausted CD8 T cells 
• TCR and cytokine signaling 
• Chemotaxis, Migration, etc 
• Metabolism 
• Transcription factors 
• PD-1 & other Inhibitory 
receptors 
Molecular Basis of CD8 T Cell Exhaustion 
1) PD-1 and  
other Inhibitory receptors 
2) Signaling 
4) Translation and metabolism 
5) Transcription factors 
3) Cytokine and  
chemokine receptors 
Tim-3 
CD200/CD200R 
CTLA-4 
CD160 
LAG3 
2B4 
PD-1 
ITIM 
Non-canonical “ITIM” 
ITSM 
KIEELE motif 
PD-L1/L2 
CD48 
MHCII 
HVEM 
B71/2 
Gal9 
CD200/CD200R 
Y 
Y ? 
Y Y 
Y 
Exhausted T cells express many inhibitory receptors 
Block:    PD-L1 
  LAG-3 
  PD-L1+LAG-3 
Analyze:  T cell response 
     Viral control 
Targeting multiple inhibitory receptors: 
Blocking PD-1:PD-L and LAG-3 during chronic 
LCMV infection 
Targeting multiple inhibitory receptors: 
Blocking PD-1:PD-L and LAG-3 
2B4 
CD160 LAG3 
PD-1 
Blackburn et al Nature Immunology 2009 
X 
X 
• aPD-1 + aCTLA-4 
 
• aPD-1 + aLAG-3 
 
• aPD-1 + aTim-3  
 
Long list of other pathways 
of interest: 
• BTLA, 2B4, CD160, NKG2A, 
KLRG1, LAIR1, Ly49/KIRs, 
CD200/CD200R, PilrB, 
CEACAM, CD5, etc 
• IL-10, Tgfb, IFN-I, etc. 
 
Synergistic co-targeting of multiple inhibitory 
receptors 
Summary – Part I 
• T cell exhaustion occurs in many settings of 
chronic infection and cancer 
 
• Molecular profiling and “discovery” science 
in a basic animal model can lead to 
clinically relevant findings 
 
• PD-1 and many other inhibitory receptors 
are central to regulation of T cell exhaustion 
and are important clinical targets 
 
 
 
Current directions and other insights 
from studying T cell exhaustion 
T cell responses to acute and chronic 
infections 
• Highly functional 
• Rapid & robust secondary 
response 
• Long-term Ag-independent 
maintenance 
•Lose effector functions 
•Poorly protective 
•Actively inhibited 
•Ag-dependent maintenance 
& constant proliferation 
•Long-term host-pathogen 
stalemate 
Is there heterogeneity in exhausted 
T cell populations? 
Subsets of exhausted CD8 T cells during 
chronic infection 
Paley et al Science 2012; Blackburn et al PNAS 2008 
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Maintenance of CD8 T cells during chronic infection 
• PD-1Int 
• Retain some proliferative capacity 
• “Centrally” located 
• Depleted by prolonged infection 
• Respond to PD-1 blockade 
 
 
 
• PD-1Hi + other IR 
• Better cytotoxicity 
• Terminally differentiated 
• Peripheral localization 
• Non-reversible Blackburn et al PNAS 2008 
Paley et al Science 2012 
What is the role of persisting 
inflammation? 
Memory CD8 T cell development 
in the presence of a bystander chronic infection 
OT1  
(Ly5.2+) 
Ly5.1+ 
VSV-OVA 
8 days 
effector CD8 
control 
Ly5.1+ 
30 days 
chronic  
(LCMV clone13) 
FACS analysis 
effector differentiation 
a), b), c) 
memory differentiation 
d) 
Stelekati et al Immunity In Press 
30 days post-transfer 
Memory CD8 T cell development 
in the presence of a bystander chronic infection 
Stelekati et al., Figure 1 
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What about memory CD8 T 
cell quality? 
Stelekati et al Immunity In Press 
Defective memory in the presence of bystander 
chronic infection 
gated on donor Ly5.2+ OT1 CD8 T cells  
Long-term 
Persisting 
Memory 
Terminally 
Differentiated 
Effectors 
IL-7Ra 
K
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G
1
 
 CD62L, CXCR3, CD27 
 IL-2 
Effector T cells become more terminally differentiated when exposed to chronic 
inflammation  
control 
chronic 
9% 
69% 
45% 
40% 
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Stelekati et al Immunity In Press 
“Effector TF”: 
Common central 
regulators 
IFNAR 
IL-12R ? 
Common regulators of the effects of inflammatory pathways 
Defined a key role for the transcription factors Blimp-1 and T-bet in 
integrating the effects of chronic bystander inflammation 
STATs 
STATs 
T-bet  Blimp-1 
Effects of bystander chronic infections 
IFNAR 
T-bet 
Inflammation 
Blimp-1 
naive CD8 effector memory 
• IFN-I and/or IL-12 implicated, but these pathways 
are downregulated during chronic viral infection 
(Zuniga, et al Cell Host and Microbe). 
 
• Removing the ability to sense IFN-I, IFN-g, or IL-12 
does not prevent skewed memory 
 
• Removing Blimp-1 or T-bet restores memory CD8 T 
cell differentiation 
 
• Implications for vaccines in chronically infected, 
inflammated and/or coinfected populations 
 
• Should we have different vaccine expectations in 
co-infected populations? 
 
Unexpected insights from studying 
molecular mechanisms of exhaustion 
PD-1 regulates CD8 T cell function through BATF 
40 
2010 
Wanted to understand how BATF might control T cell exhaustion 
BATF, together with IRF4, as a coordinator 
of Th17 responses 
41 
Nature 2012 
Science 2012 
Cell 2012 
Nature 2009 
Severely diminished effector CD8 T cell response without BATF 
Adoptive transfer experiment with 250+250 P14 cells 
Gated on P14 cells 
× 406 
# of P14 in SPL Arm
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Kurachi and Barnitz et al. Nat. Immunol. 2014 
How does BATF function to control effector CD8 
T cell differentiation? 
BATF ChIP-Seq in CD8 T cells 
Kurachi and Barnitz et al. Nat. Immunol. 2014 
BATF targets include a wide program of 
effector T cell genes 
45 
Kurachi and Barnitz et al. Nat. Immunol. 2014 
A hierarchical cascade of TF in effector T cells 
46 
Vahedi et al Im. Rev. 2013 
T-bet 
Blimp-1 
Rorgt 
GATA3 
BATF 
SUMMARY - BATF 
 
• BATF is a master regulator of effector CD8 T cell 
differentiation 
 
• BATF controls many genes involved in the NE transition 
 
• Data suggests BATF at the “top” of a hierarchy of effector 
CD8 T cell circuitry 
 
• Aberrant activation sequence and collapse of differentiation 
and survival in the absence of BATF suggest a fundamental 
role in coordinating activation 
 
• Addressing questions about T cell exhaustion led to a 
fundamental new understanding of effector and memory T 
cell differentiation 
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